These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An indication for use of imipramine in attention deficit disorder. Cox WH Am J Psychiatry; 1982 Aug; 139(8):1059-60. PubMed ID: 7091433 [TBL] [Abstract][Full Text] [Related]
3. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report. Dillon DC; Salzman IJ; Schulsinger DA J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138 [TBL] [Abstract][Full Text] [Related]
4. Use of imipramine for attention deficit disorder in a borderline patient. Satel S; Southwick S; Denton C J Nerv Ment Dis; 1988 May; 176(5):305-7. PubMed ID: 3367147 [TBL] [Abstract][Full Text] [Related]
5. Imipramine. St Dennis C; Synoground G J Sch Nurs; 1995 Oct; 11(3):8-10. PubMed ID: 7580037 [No Abstract] [Full Text] [Related]
6. Motor performance in hyperactive children treated with imipramine. Gualtieri CT; Evans RW Percept Mot Skills; 1988 Jun; 66(3):763-9. PubMed ID: 3043370 [TBL] [Abstract][Full Text] [Related]
7. [Use of drugs in attention deficit hyperactivity disorders]. Guardiola A; Terra AR; Pereira KR; Rotta NT Arq Neuropsiquiatr; 1997 Sep; 55(3B):594-7. PubMed ID: 9629412 [TBL] [Abstract][Full Text] [Related]
8. Use of tricyclics. Huessy HR J Dev Behav Pediatr; 1984 Jun; 5(3):142. PubMed ID: 6736262 [No Abstract] [Full Text] [Related]
9. Imipramine in the treatment of minimal brain dysfunction in children. Gross MD Psychosomatics; 1973; 14(5):283-5. PubMed ID: 4794958 [No Abstract] [Full Text] [Related]
10. Tricyclic antidepressants in the treatment of children with attention deficit disorder. Pliszka SR J Am Acad Child Adolesc Psychiatry; 1987 Mar; 26(2):127-32. PubMed ID: 3584008 [No Abstract] [Full Text] [Related]
12. Imipramine treatment of ADHD in a fragile X child. Hilton DK; Martin CA; Heffron WM; Hall BD; Johnson GL J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):831-4. PubMed ID: 1938802 [TBL] [Abstract][Full Text] [Related]
13. Attention deficit and hyperactivity disorder: a therapeutic option. Topczewski A Einstein (Sao Paulo); 2014 Sep; 12(3):310-3. PubMed ID: 25295451 [TBL] [Abstract][Full Text] [Related]
14. Consequences of abrupt reduction of chronic symptoms. Satel SL; Southwick S Am J Psychiatry; 1987 Oct; 144(10):1362. PubMed ID: 3661773 [No Abstract] [Full Text] [Related]
15. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine. Millichap JG Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851 [No Abstract] [Full Text] [Related]
16. Reboxetine use in the treatment of attention-deficit/hyperactivity disorder. Cak HT; Cetin FC J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):803-4. PubMed ID: 17201625 [No Abstract] [Full Text] [Related]
18. The myth of attention deficit-hyperactivity disorder: symptoms resulting from multiple causes. Weinberg WA; Brumback RA J Child Neurol; 1992 Oct; 7(4):431-45; discussion 446-61. PubMed ID: 1469255 [No Abstract] [Full Text] [Related]
19. Effects of imipramine hydrochloride on the EEG of children with Attention-Deficit/Hyperactivity Disorder who are non-responsive to stimulants. Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Johnstone SJ Int J Psychophysiol; 2008 Jun; 68(3):186-92. PubMed ID: 18304665 [TBL] [Abstract][Full Text] [Related]
20. Growth deficits and desipramine. Holt KG J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1167-8. PubMed ID: 1429424 [No Abstract] [Full Text] [Related] [Next] [New Search]